Cassava Sciences | PTIE - Capitale Ordinario

Prezzo Delle Azioni
1.24
Cambio Giornaliero
0.01 0.81%
Mensile
-22.98%
Annuale
-39.51%
Q2 Previsione
1.27




Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 540M 1000K 2026-03
Biogen USD 146.7M 200K 2025-09
Cara Therapeutics USD 9.38M 9.38M 2025-09
Cassava Sciences USD 48.31M 0 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Geron USD 640.9M 2.54M 2026-03
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.91B 60K 2026-03
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 13M 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12